Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 505

1.

Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.

Bainbridge JW, Mistry A, Schlichtenbrede FC, Smith A, Broderick C, De Alwis M, Georgiadis A, Taylor PM, Squires M, Sethi C, Charteris D, Thrasher AJ, Sargan D, Ali RR.

Gene Ther. 2003 Aug;10(16):1336-44.

PMID:
12883530
2.

Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery.

Weber M, Rabinowitz J, Provost N, Conrath H, Folliot S, Briot D, Chérel Y, Chenuaud P, Samulski J, Moullier P, Rolling F.

Mol Ther. 2003 Jun;7(6):774-81.

PMID:
12788651
3.

Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG.

Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9920-5.

4.

Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.

Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ, Maguire AM, Jacobson SG, Bennett J.

Mol Ther. 2001 Nov;4(5):461-72.

5.

Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography.

Rolling F, Shen WY, Tabarias H, Constable I, Kanagasingam Y, Barry CJ, Rakoczy PE.

Hum Gene Ther. 1999 Mar 1;10(4):641-8.

PMID:
10094207
6.

Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?

Glushakova LG, Timmers AM, Issa TM, Cortez NG, Pang J, Teusner JT, Hauswirth WW.

Mol Vis. 2006 Apr 7;12:298-309.

7.

Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina.

McGee Sanftner LH, Rendahl KG, Quiroz D, Coyne M, Ladner M, Manning WC, Flannery JG.

Mol Ther. 2001 May;3(5 Pt 1):688-96.

8.

Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.

Glushakova LG, Timmers AM, Pang J, Teusner JT, Hauswirth WW.

Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3505-13.

PMID:
16877422
9.

Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.

Shen WY, Lai CM, Lai YK, Zhang D, Zaknich T, Sutanto EN, Constable IJ, Rakoczy PE.

J Gene Med. 2003 Jul;5(7):576-87.

PMID:
12825197
10.

Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.

Rolling F.

Gene Ther. 2004 Oct;11 Suppl 1:S26-32. Review.

PMID:
15454954
11.

Development and evaluation of the specificity of a cathepsin D proximal promoter in the eye.

Sutanto EN, Zhang D, Lai YK, Shen WY, Rakoczy EP.

Curr Eye Res. 2005 Jan;30(1):53-61.

PMID:
15875365
12.

Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV.

Dudus L, Anand V, Acland GM, Chen SJ, Wilson JM, Fisher KJ, Maguire AM, Bennett J.

Vision Res. 1999 Jul;39(15):2545-53.

13.

Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.

Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F.

Gene Ther. 2007 Feb;14(4):292-303. Epub 2006 Oct 5.

PMID:
17024105
14.

Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection.

Doi K, Hargitai J, Kong J, Tsang SH, Wheatley M, Chang S, Goff S, Gouras P.

Vision Res. 2002 Feb;42(4):551-8.

15.

Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.

Narfström K, Katz ML, Bragadottir R, Seeliger M, Boulanger A, Redmond TM, Caro L, Lai CM, Rakoczy PE.

Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1663-72.

PMID:
12657607
16.

Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization.

Bainbridge JW, Mistry A, Binley K, De Alwis M, Thrasher AJ, Naylor S, Ali RR.

Gene Ther. 2003 Jun;10(12):1049-54.

PMID:
12776163
17.

Cone-specific expression using a human red opsin promoter in recombinant AAV.

Li Q, Timmers AM, Guy J, Pang J, Hauswirth WW.

Vision Res. 2008 Feb;48(3):332-8. Epub 2007 Oct 1.

18.

Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain.

Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, Le Meur G, Deschamps JY, Provost N, Nivard D, Cherel Y, Moullier P, Rolling F.

Mol Ther. 2008 May;16(5):916-23. doi: 10.1038/mt.2008.41. Epub 2008 Mar 11.

PMID:
18388922
19.

Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.

Balaggan KS, Binley K, Esapa M, Iqball S, Askham Z, Kan O, Tschernutter M, Bainbridge JW, Naylor S, Ali RR.

J Gene Med. 2006 Mar;8(3):275-85.

PMID:
16299834
20.

Additional transduction events after subretinal readministration of recombinant adeno-associated virus.

Anand V, Chirmule N, Fersh M, Maguire AM, Bennett J.

Hum Gene Ther. 2000 Feb 10;11(3):449-57.

PMID:
10697119
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk